Perioperative & Surgical Care
Postoperative fever: timing-based workup (5 Ws)
— Wind (atelectasis/pneumonia): POD 1–2
— Water (UTI, often catheter-associated): POD 3–5
— Walking (DVT/PE): POD 4–6
— Wound (surgical site infection, SSI): POD 5–7
— Wonder drugs / What did we do? (drug fever, transfusion reaction, line infection, abscess, C. difficile): POD 7+
— T >39°C, rigors, hemodynamic instability, leukocytosis with bandemia, lactate elevation, or new organ dysfunction
— Fever persisting beyond POD 4 or recurring after defervescence
— Fever in immunocompromised, prosthetic implant, or transplant patients — lower threshold for full workup
Board pearl: Atelectasis is overstated as a fever cause — recent literature shows no strong causal link, but the 5 Ws framework remains the dominant Step 3 testing schema. Answer atelectasis only if the stem clearly points to POD 1 fever with decreased breath sounds and no other findings.
Step 3 management: Tailor workup intensity to timing and clinical picture — not every postop fever needs pan-cultures and CT. Reflexive shotgun testing wastes resources and yields false positives.

— Rapid-onset hyperthermia, masseter rigidity, hypercarbia after succinylcholine/volatile agent → malignant hyperthermia
— Fever + hypotension + hives during transfusion → acute hemolytic or febrile non-hemolytic transfusion reaction
— Pre-existing infection not recognized preoperatively (cholangitis, occult pneumonia)
— Drug fever — relative bradycardia, eosinophilia, rash; β-lactams, sulfa, phenytoin, heparin
— Central line infection — fever spikes with line use, erythema at site
— C. difficile — diarrhea after perioperative antibiotics
— Intra-abdominal abscess — persistent fever, leukocytosis, anorexia after abdominal surgery
Key distinction: Anastomotic leak after bowel surgery typically presents POD 5–7 with fever, tachycardia, ileus, and leukocytosis — do not mistake for routine wound infection. Tachycardia often precedes overt peritonitis by 24 h and is the earliest sign.
Board pearl: Always ask about preop antibiotics, transfusions, anesthetic agents, indwelling devices (Foley, central line, drains, epidural), and DVT prophylaxis adherence — each maps to a specific 5 Ws bucket.

— Distention, absent bowel sounds, peritoneal signs → anastomotic leak, abscess, ischemic bowel
— RUQ tenderness, Murphy sign → acalculous cholecystitis (critically ill, NPO, TPN)
— Costovertebral angle tenderness → pyelonephritis
— Erythema, warmth, fluctuance, purulent drainage, crepitus (necrotizing infection — surgical emergency)
— Dehiscence with salmon-colored fluid = impending evisceration
Step 3 management: Hemodynamically unstable postop fever → activate sepsis protocol: 2 large-bore IVs, blood cultures ×2 (one peripheral, one from each line), lactate, broad-spectrum antibiotics within 1 h, 30 mL/kg crystalloid if hypotensive or lactate ≥4.
Board pearl: Crepitus + pain out of proportion + bullae at incision = necrotizing fasciitis — immediate OR, do not wait for imaging.

— Often no workup needed — encourage incentive spirometry, ambulation, pain control
— Reassess in 12–24 h
— CBC with differential — leukocytosis with left shift suggests infection; eosinophilia → drug fever
— BMP — renal function, electrolytes, glucose (hyperglycemia worsens SSI risk)
— LFTs — if RUQ pain or concern for cholangitis/cholecystitis
— Lactate — sepsis screening; >2 concerning, ≥4 = severe
— Urinalysis + urine culture — POD 3+ or any Foley patient
— Blood cultures ×2 from separate sites — before antibiotics; mandatory if T >38.3, rigors, hemodynamic change, indwelling line, or prosthetic device
— CXR — POD 1–2 fever with respiratory symptoms; assess atelectasis, infiltrate, effusion, line position
— ECG — if chest pain, tachycardia, or concern for PE/MI
— Procalcitonin — supportive but not standalone; rises in bacterial infection, less so in viral/inflammatory. Useful for antibiotic stewardship/de-escalation.
— CRP — rises after any surgery; falling trend reassuring, rising trend after POD 3–4 suggests complication
Key distinction: A normal WBC does not exclude infection in elderly or immunosuppressed patients — clinical picture and lactate matter more.
CCS pearl: On CCS, for postop fever, order in this sequence: vitals → physical exam → CBC, BMP, UA, blood cultures ×2, CXR → then targeted imaging. Move clock 4–6 h between reassessments unless unstable.

— CT abdomen/pelvis with IV + oral contrast — gold standard for intra-abdominal abscess, anastomotic leak, collection, ischemia. Sensitivity >90% for abscess.
— CT chest — empyema, loculated effusion, occult pneumonia
— CT-PA — gold standard for PE; preferred over V/Q in most postop patients
— Lower extremity compression duplex — first-line for DVT; bedside, no contrast
— RUQ US — acalculous cholecystitis (wall thickening >3.5 mm, pericholecystic fluid, sludge, sonographic Murphy)
— Echocardiogram — TTE if bacteremia + new murmur; TEE if prosthetic valve or persistent bacteremia (endocarditis workup, Duke criteria)
— Diagnostic paracentesis — postop ascites with fever to evaluate for peritonitis
— Thoracentesis — parapneumonic effusion vs empyema (pH <7.2, glucose <40, LDH high → drain)
— CT-guided aspiration — confirms and treats abscess simultaneously
Board pearl: Persistent fever POD 5–7 after bowel surgery + tachycardia + leukocytosis → CT abd/pelvis with contrast looking for anastomotic leak or abscess is the single highest-yield study. Do not delay for "watchful waiting."
Step 3 management: Image-guided percutaneous drainage is preferred over surgical re-exploration for well-defined abscesses in stable patients — minimally invasive, cultures guide antibiotics.

— Stable + POD 0–2 + low-grade fever + no localizing findings → observation, incentive spirometry, ambulation, pain control. No empiric antibiotics.
— Stable + localizing source identified → targeted workup, source-directed therapy
— Unstable (qSOFA ≥2, lactate ≥2, hypotension) → sepsis protocol, empiric broad-spectrum antibiotics within 1 h, ICU consideration
— Remove infected lines and Foleys when feasible
— Drain abscesses (percutaneous or surgical)
— Debride necrotic tissue
— Repair anastomotic leaks (operative vs diversion vs drainage depending on stability and contamination)
— Cultures drawn? (blood, urine, wound if purulent, line if suspected)
— Source identified or actively being sought?
— Coverage appropriate to surgical site and local antibiogram?
— Stewardship — narrow within 48–72 h based on cultures
— Immunosuppression (transplant, chemo, steroids, biologics)
— Diabetes with poor glycemic control (hyperglycemia >180 worsens outcomes)
— Prosthetic implants (joint, valve, vascular graft, mesh)
— Recent broad-spectrum antibiotics (resistant organisms, C. difficile)
— Prolonged ICU/ventilator stay
— Malnutrition, age >70
— Floor-level: stable, identified source, responding to therapy
— Step-down/ICU: vasopressor need, respiratory failure, source control pending
— OR: necrotizing infection, peritonitis, uncontained leak, dehiscence
CCS pearl: Order glucose control (insulin to keep 140–180), VTE prophylaxis continuation, head-of-bed elevation, early ambulation, and incentive spirometry as standing orders on every postop fever case — these reduce subsequent complications.
Key distinction: Fever alone ≠ infection. Treating every postop fever empirically with antibiotics is a wrong-answer trap on Step 3.

— Antipseudomonal β-lactam (piperacillin-tazobactam or cefepime) + MRSA coverage (vancomycin or linezolid) if risk factors (recent IV antibiotics, prior MRSA, ICU)
— Add second antipseudomonal (aminoglycoside or fluoroquinolone) only if shock or high resistance risk
— Remove or change catheter
— Ceftriaxone for uncomplicated; piperacillin-tazobactam or carbapenem if sepsis, prior resistant organisms, or healthcare exposure
— Piperacillin-tazobactam or ceftriaxone + metronidazole
— Add vancomycin if MRSA risk; add antifungal (fluconazole/echinocandin) if perforated upper GI, immunosuppressed, or persistent fever on antibacterials
— Superficial: open, drain, culture; antibiotics often unnecessary if drained and minimal cellulitis
— Deep/organ-space: empiric cefazolin (clean), vancomycin if MRSA risk, broaden with metronidazole for GI/GU surgery
— Necrotizing: vancomycin + piperacillin-tazobactam + clindamycin (toxin suppression) — surgical debridement is definitive
— Vancomycin empirically; add gram-negative coverage if neutropenic/septic/femoral line
— Remove line for S. aureus, gram-negative bacilli, Candida, or persistent bacteremia
— First episode, non-severe or severe: oral fidaxomicin preferred; oral vancomycin acceptable alternative
— Fulminant (ileus, megacolon, shock): oral/NG vancomycin + IV metronidazole ± rectal vancomycin
— Drug fever → stop offending agent; defervesces within 48–72 h
— Transfusion reaction → stop transfusion, supportive care
— Malignant hyperthermia → dantrolene 2.5 mg/kg IV, cooling, stop trigger
Board pearl: De-escalate antibiotics at 48–72 h based on culture data. Failure to narrow is a stewardship and exam-favorite error.
Step 3 management: Always document indication, planned duration, and stop date when initiating antibiotics — core measure in inpatient antibiotic stewardship.

— Percutaneous CT- or US-guided drainage is first-line for well-defined collections ≥3 cm in stable patients
— Send fluid for Gram stain, aerobic/anaerobic culture, fungal, AFB if indicated
— Leave drain until output <10–20 mL/day and clinically improved; repeat imaging if persistent
— Surgical drainage if multiloculated, inaccessible, or failed percutaneous approach
— Contained, stable patient: percutaneous drainage + bowel rest + antibiotics + nutrition support (TPN or distal feeding)
— Uncontained or unstable: emergent OR — washout, diversion (proximal stoma), drain placement; primary repair rarely successful in inflamed field
— Endoscopic stent or clip for select esophageal/upper GI leaks
— Open the wound (remove staples/sutures over infected area), evacuate purulence, irrigate, pack
— Wet-to-dry or negative-pressure wound therapy (NPWT) for large defects
— Delayed primary closure or secondary intention healing
— Emergent surgical debridement within hours — every hour of delay increases mortality
— Serial debridements every 24–48 h until clean margins
— Broad-spectrum antibiotics + clindamycin for toxin suppression
— Remove peripheral IV at any sign of phlebitis
— Remove central line for S. aureus, gram-negative, Candida, septic shock, tunnel/pocket infection
— Salvage attempt with antibiotic lock therapy reasonable for select CoNS bacteremia in tunneled lines
CCS pearl: When ordering drainage, always specify: imaging guidance modality, culture studies on aspirate, drain to gravity vs suction, and reassessment imaging timeline (typically 48–72 h).
Board pearl: Persistent fever despite appropriate antibiotics = search for undrained source, not "broaden antibiotics."

— Blunted febrile response — may have infection with normal or low-grade temperature; rely on tachycardia, hypotension, AMS, functional decline
— Delirium is often the only presenting sign of UTI, pneumonia, or sepsis — workup any acute change in mental status with infection screen
— Higher baseline risk for: pneumonia (aspiration, deconditioning), UTI (BPH, prolapse, incomplete emptying), pressure injuries, C. difficile
— Polypharmacy increases drug fever risk
— Lower threshold to image; higher threshold for "watchful waiting"
— Vancomycin: dose by AUC/MIC (target AUC 400–600 mg·h/L) or trough 15–20 in severe infection; adjust frequency by CrCl
— Piperacillin-tazobactam: extend interval to q8h or q12h with reduced CrCl
— Aminoglycosides: avoid if possible; extended-interval dosing with strict level monitoring
— Fluoroquinolones: dose reduction for CrCl <50
— Avoid nitrofurantoin if CrCl <30 (inadequate urinary concentration)
— Cefepime: neurotoxicity (encephalopathy, myoclonus, NCSE) in renal impairment — adjust dose strictly
— Avoid or reduce: tigecycline, ceftriaxone (biliary sludging), metronidazole (prolonged half-life), antifungals (voriconazole)
— Watch for acetaminophen toxicity from antipyretic use — cap at 2 g/day in cirrhosis
— Coagulopathy complicates drain placement and surgical re-intervention
— Goals-of-care discussion early — aggressive workup may not align with patient preferences
— Higher mortality from sepsis; lower physiologic reserve
Key distinction: In elderly, absence of fever does not exclude sepsis — use SIRS/qSOFA with mental status and hemodynamics as primary triggers.
Step 3 management: Renally dose every antibiotic at initiation and recheck dosing daily as creatinine evolves — acute kidney injury is common postoperatively and missed dose adjustments cause toxicity (especially cefepime neurotoxicity and vancomycin AKI).

— Endometritis — most common cause after C-section (POD 2–5): fever, uterine tenderness, foul lochia → clindamycin + gentamicin IV
— Septic pelvic thrombophlebitis — persistent fever despite antibiotics, "picket-fence" pattern → add anticoagulation
— Avoid: tetracyclines, fluoroquinolones, aminoglycosides (relative), sulfa near term
— Safe: penicillins, cephalosporins, clindamycin, metronidazole (after first trimester), vancomycin
— Mastitis postpartum: dicloxacillin or cephalexin; continue breastfeeding
— Lower threshold for full sepsis workup in neonates and infants (blunted localization)
— Weight-based dosing; avoid ceftriaxone in neonates with hyperbilirubinemia (kernicterus) — use cefotaxime
— Atelectasis and viral URI commonly cause benign postop fever; consider influenza/RSV during season
— Neutropenic fever (ANC <500): single T ≥38.3 or sustained ≥38.0 → empiric cefepime or piperacillin-tazobactam within 1 h; add vancomycin if line, mucositis, MRSA risk, or unstable
— Broaden to antifungal (echinocandin or voriconazole) if fever persists >4–7 days
— Consider atypical pathogens: CMV, PJP, Aspergillus, Nocardia, mycobacteria
— Lower threshold for CT imaging — physical findings blunted
— Timing-based pathogen risk: <1 month → nosocomial/donor-derived; 1–6 months → opportunistic (CMV, PJP, BK); >6 months → community-acquired
— Drug interactions critical — fluoroquinolones, azoles raise tacrolimus/cyclosporine levels
— Fever may signal acute chest syndrome — CXR, hydration, transfusion, broad-spectrum antibiotics
— Functional asplenia → encapsulated organism risk (S. pneumoniae, H. influenzae)
Board pearl: Neutropenic fever is a medical emergency — antibiotics within 1 hour, do not delay for culture results.
CCS pearl: In pregnant postoperative patients, always document fetal heart tones and obstetric consultation alongside infection workup.

— AKI (ATN from hypoperfusion or nephrotoxic antibiotics)
— ARDS (often from sepsis or aspiration)
— DIC (consumptive coagulopathy)
— Hepatic dysfunction (shock liver, cholestasis of sepsis)
— Each additional organ failure roughly doubles mortality
— Peritonitis, abdominal sepsis, fistula formation
— Reoperation, prolonged ICU, stoma, prolonged TPN
— Long-term: stricture, incisional hernia, oncologic concerns (cancer recurrence higher after leak in colorectal cancer)
— Massive PE → obstructive shock, sudden death
— Submassive PE → RV strain, chronic thromboembolic pulmonary hypertension
— Post-thrombotic syndrome after DVT
— CLABSI, CAUTI, VAP, SSI, C. difficile, MRSA bacteremia — CMS does not reimburse for "never events"
— Drive institutional quality metrics
— AKI (vancomycin, aminoglycosides, piperacillin-tazobactam combination especially)
— QT prolongation (fluoroquinolones, azoles, macrolides)
— Cefepime neurotoxicity
— Selection of resistant organisms (ESBL, CRE, VRE, MDR-Pseudomonas)
Key distinction: Refractory hypotension despite source-directed therapy = suspect undrained source, resistant organism, or alternative diagnosis (adrenal insufficiency, PE, MI) — re-image and broaden workup.
Board pearl: Mortality of severe sepsis rises ~7% per hour of delayed antibiotics — the "Golden Hour" principle.

— Vasopressor requirement after adequate fluid resuscitation
— Respiratory failure (intubation, NIV, FiO₂ >50% with hypoxia)
— Lactate ≥4 or persistent >2 despite resuscitation
— Altered mental status with hemodynamic compromise
— Multi-organ dysfunction
— Need for continuous renal replacement therapy
— Postoperative complications requiring emergent reoperation with anticipated instability
— High-flow oxygen, telemetry monitoring, frequent vital signs
— Bridge while source control achieved
— Surgery (operating team) — any concern for wound, leak, abscess, intra-abdominal pathology; they own the patient
— Infectious disease — persistent fever, MDR organisms, immunocompromised host, complex antibiotic regimens, prosthetic device infections
— Interventional radiology — abscess drainage, line salvage/replacement
— Critical care — early sepsis with concern for deterioration
— Cardiology — new murmur with bacteremia (endocarditis evaluation), perioperative MI
— Pulmonology — bronchoscopy, persistent infiltrates, empyema management
— GI — endoscopic management of GI leaks, refractory C. difficile
— SBP <90, HR >130, RR >30, SpO₂ <90% on supplemental O₂, new AMS
— Patients with advanced illness, frailty, or pre-existing limitations should have early palliative care/goals discussion before invasive escalation
CCS pearl: On CCS cases, escalation orders typically include: "Transfer to ICU," "Consult general surgery for re-exploration," "Consult IR for percutaneous drainage," "Consult ID for antibiotic guidance." Order consultations in parallel with workup, not sequentially.
Step 3 management: Document a specific escalation plan and triggers in the chart — "Call MD for T >39, SBP <90, HR >120, RR >24, UOP <0.5 mL/kg/h, lactate rising" — protects patient safety and is testable.

— POD 1–5 typically; ventilator-associated >48 h post-intubation
— Fever, leukocytosis, new infiltrate, purulent secretions, hypoxia
— Sputum Gram stain/culture or BAL
— POD 3+ with Foley
— Dysuria, suprapubic pain, CVA tenderness, pyuria
— Asymptomatic bacteriuria in postop patient generally not treated unless undergoing urologic procedure or pregnant
— Superficial (skin/subcutaneous): erythema, drainage; open and drain
— Deep (fascia/muscle): may need OR exploration
— Organ/space: abscess, peritonitis, mediastinitis (post-cardiac surgery)
Board pearl: Persistent fever on POD 7+ with negative initial workup → CT abd/pelvis is highest-yield study to find occult abscess or leak.
Key distinction: Bacteremia + indwelling hardware (prosthetic valve, joint, vascular graft) → assume device infection until proven otherwise; ID consult mandatory.

— Any time but classically POD 7+
— Relative bradycardia, eosinophilia, rash; well-appearing despite high fever
— Common culprits: β-lactams, sulfonamides, phenytoin, heparin, anticonvulsants, antipsychotics
— Resolves within 48–72 h of stopping agent
— POD 4–6 typically
— Unilateral leg swelling, pleuritic chest pain, dyspnea, tachycardia
— D-dimer unhelpful postop; go to imaging (compression US, CT-PA)
— Febrile non-hemolytic (most common): fever + chills during/within 6 h
— Acute hemolytic: fever + hypotension + hemoglobinuria (ABO mismatch — patient safety event)
— TRALI: respiratory distress within 6 h of transfusion
Step 3 management: Workup non-infectious causes in parallel with infectious workup — don't anchor.
Board pearl: Fever + relative bradycardia + eosinophilia + rash + well-appearing = drug fever — stop the drug, watch for resolution.

— Prophylactic antibiotics within 60 min of incision (120 min for vancomycin/fluoroquinolones), redose for long cases or large blood loss
— Hair clipping (not shaving), chlorhexidine skin prep, normothermia, normoglycemia, supplemental O₂
— Smoking cessation 4+ weeks preop
— Optimize nutrition (albumin, prealbumin), glycemic control (HbA1c <8 ideally)
— MRSA decolonization (nasal mupirocin + chlorhexidine bath) for cardiac/orthopedic implant cases
— VAP bundle: HOB 30°, daily sedation interruption, spontaneous breathing trials, oral care with chlorhexidine, DVT/PUD prophylaxis
— CAUTI prevention: remove Foley as soon as possible (within 48 h ideally); consider straight cath instead
— CLABSI prevention: full-barrier insertion, chlorhexidine prep, daily line necessity assessment, remove as soon as possible
— SSI prevention: incision care education, dressing protocols
— VTE prophylaxis: LMWH or mechanical (SCDs); duration extends 4 weeks post-op for major orthopedic and cancer abdominopelvic surgery
— Complete antibiotic course (oral if possible; OPAT — outpatient parenteral antimicrobial therapy — with PICC if IV needed)
— Wound care instructions, dressing changes, return precautions (fever, drainage, dehiscence, increasing pain)
— Drain management with output logs
— Glycemic control, nutrition support
— Smoking cessation reinforcement
— Incisional hernia surveillance after deep SSI
— Recurrent C. difficile prophylaxis (fidaxomicin, bezlotoxumab in select recurrence)
— Endocarditis prophylaxis if applicable (prosthetic valve, prior endocarditis)
Key distinction: Antibiotic prophylaxis is given once preoperatively (with redosing rules) — continuing antibiotics postop for "prophylaxis" beyond 24 h is not indicated for most procedures and is a frequent quality measure failure.
Step 3 management: Document return precautions and follow-up appointments in the discharge summary — transition of care is testable as a patient safety domain.

— Daily vitals trend (fever curve, HR, BP, O₂ requirement)
— Daily CBC, BMP; CRP/procalcitonin trends every 48–72 h
— Repeat blood cultures at 48–72 h if S. aureus, Candida, or persistent bacteremia until clearance documented
— Drain output character and volume; remove when <10–20 mL/day serous
— Wound exam daily
— Glucose 4× daily, insulin sliding scale or basal-bolus
— Vancomycin trough/AUC, q3–7 day re-dosing
— Aminoglycoside levels, renal function daily
— Liver enzymes weekly for prolonged courses
— Re-evaluate need at 48–72 h, narrow based on cultures, set planned end date
— Repeat CT for abscess at 5–7 days if not clinically improving
— Echocardiogram repeat for endocarditis to assess vegetation, perivalvular extension
— Surgical follow-up in 1–2 weeks (wound check, staple/suture removal)
— Earlier (3–7 days) if SSI, drain in place, or complex postop course
— Primary care visit within 2 weeks for medication reconciliation, transition-of-care issues
— ID follow-up for OPAT, prosthetic device infections, prolonged courses
— Return precautions: fever >38.3, increased pain, redness/drainage from wound, dehiscence, shortness of breath, calf swelling, persistent diarrhea
— Antibiotic adherence and completion
— Avoid soaking incisions for 2–4 weeks; showering generally OK after 48 h
— Activity restrictions specific to procedure (no heavy lifting 4–6 weeks after abdominal surgery)
— Smoking cessation — wound healing benefit
— DVT prophylaxis adherence if prescribed at discharge
CCS pearl: On CCS, always schedule a post-discharge follow-up visit with the appropriate specialty (surgery 1–2 weeks, PCP 2 weeks, ID as indicated) and order medication reconciliation before discharge — Step 3 weights transitions of care heavily.
Board pearl: Patients on chronic immunosuppression or with prosthetic devices need indefinite vigilance for late infections — counsel on lifelong return precautions.

— Handoff communication failures cause medication errors, missed cultures, and delayed antibiotic adjustments
— Use structured handoff tools (I-PASS, SBAR)
— Medication reconciliation at every transition (admission, transfer between units, discharge)
— Discharge summary must reach PCP within 48 h; pending culture results require explicit follow-up assignment
— New consent required for additional procedures (re-exploration, drainage, chest tube) — original surgical consent does not cover unrelated subsequent interventions
— Emergency exception (implied consent) applies only to life-threatening situations where delay would cause harm; document rationale
— Surrogate decision-making hierarchy for incapacitated patients (spouse → adult children → parents → siblings, varies by state)
— Wrong-site surgery, retained foreign body, air embolism, mismatched blood transfusion, surgical site infection after CABG/bariatric/orthopedic implant, CAUTI, CLABSI
— Institutional reporting and quality review required
— Hospitals not reimbursed for care related to these events
— Reportable infections (TB, certain MDR organisms, healthcare-associated outbreaks)
— Suspected abuse if discovered during care
— Inappropriate antibiotic use contributes to community resistance, C. difficile epidemics, individual harm
— Document indication and stop date; de-escalate at 48–72 h
— Ethical obligation to disclose harm to patient/family
— Apology and explanation reduce litigation risk; many states have apology protection laws
— Sepsis in advanced illness or frail elderly — early palliative care consultation; aligning aggressive interventions with patient values
— Code status discussion at admission and reassessment with clinical change
— Avoid unnecessary imaging, cultures, antibiotics
— Choose Wisely campaigns relevant to postop fever (e.g., no asymptomatic bacteriuria treatment)
Step 3 management: When a postoperative complication occurs, disclose to patient, document factually, file safety event report, and engage risk management — this is a tested patient-safety pathway.
Board pearl: Pending culture results at discharge require explicit handoff to outpatient provider — failure to follow up is a documented malpractice driver.

— Wind (POD 1–2) → atelectasis, pneumonia
— Water (POD 3–5) → UTI
— Walking (POD 4–6) → DVT/PE
— Wound (POD 5–7) → SSI
— Wonder drugs / What we did (POD 7+) → drug fever, line, abscess, C. difficile
Board pearl: "Postop fever + tachycardia out of proportion + bowel surgery" → leak until proven otherwise. CT with contrast.
Key distinction: Not every fever needs antibiotics — match the workup to the day and the patient.

Step 3 management: Read the POD number first, then match to the 5 Ws bucket — this eliminates 2–3 distractors immediately.
Board pearl: "Best next step" questions favor least invasive correct workup matched to the POD timing.

Postoperative fever is approached by matching the day of fever to the 5 Ws (Wind, Water, Walking, Wound, Wonder drugs), tailoring workup intensity to clinical picture, and prioritizing source control over reflexive empiric antibiotics.
Board pearl: The single highest-yield Step 3 reflex is: POD 5–7 fever + tachycardia after bowel surgery = CT abdomen/pelvis with contrast looking for anastomotic leak, with early surgical consultation.
Key distinction: Prophylactic antibiotics end within 24 h of surgery; therapeutic antibiotics begin only after cultures are drawn and a source is suspected — confusing these is a common exam and stewardship error.
Step 3 management: Always document return precautions, scheduled follow-up, pending culture handoff, and medication reconciliation at discharge — postoperative transitions of care are heavily weighted on Step 3 as a patient safety domain.

